Search
for
Sort by
Research 511–540 of 1000+
- Spironolactone May Reduce the Risk of Incident Rosacea
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- An Overview of Chemotherapy Side Effects on Patients with Prostate Cancer, Bladder Cancer, and Testicular Cancer at Haji Adam Malik General Hospital Medan from 2020-2022
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Cronkhite-Canada syndrome associated with colon cancer metastatic to liver
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Hair disorders in patients with cancer
- Redefining hormone resistance in prostate cancer
- Dermatologic Adverse Events from Cancer Treatments
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Epigenetic regulation in adult stem cells and cancers
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- DNA Methylation‐Regulated ZDHHC17 Promotes the Risk of Facial Skin Aging
- Chemotoxicity in Carcinoma Breast Patients - Its Incidence and Trends in Severity - An Observational Study
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Psychological burden of alopecia areata in patients with cancer: A narrative review